The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine
After months of debate and intense research concerning hydroxychloroquine, FDA officials on Monday revoked their Emergency Use Authorization (EUA) for…
After months of debate and intense research concerning hydroxychloroquine, FDA officials on Monday revoked their Emergency Use Authorization (EUA) for…
A chemist displays hydroxychloroquine tablets. On June 15, 2020, U.S. regulators are revoking emergency authorisation for the tablets. File |…
The anti-malarial drug was touted by Trump as a potential “game changer” in fight against COVID-19 India has lifted export…
BENGALURU (Reuters) - India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by U.S. President Donald Trump…
NEW YORK/LONDON (Reuters) - An influential medical journal article that found hydroxychloroquine increased the risk of death in COVID-19 patients…
The Lancet on Thursday retracted a study that raised safety fears over the use of a drug favoured by President…
FILE PHOTO: The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020. REUTERS/Charles PlatiauPARIS…
The Union government on Friday asserted that India had “sufficient buffer” of the much in demand drug hydroxychloroquine (HCQ). Export…
In time of need: On hydroxychloroquine export Irrespective of whether India bowed to U.S. pressure, it is unlikely to run…
In a letter to Prime Minister Narendra Modi seeking supply of anti-malarial drug hydroxychloroquine, Brazilian President Jair Bolsonaro invoked ancient…
President Donald Trump has warned India that the US may retaliate if it did not export anti-malarial drug Hydroxychloroquine despite…